Mergers and acquisitionsArrowhead Pharmaceuticals announced that its subsidiary, Visirna Therapeutics, has sold the rights to its investigational drug, plozasiran, for the tr...
Mergers and acquisitionsLigand Pharmaceuticals announced the completion of its merger with Channel Therapeutics, forming Pelthos Therapeutics. Pelthos will launch ZELSUVMI™ ...
Mergers and acquisitionsCantargia AB has announced an agreement with Otsuka Pharmaceutical for the acquisition of Cantargia's CAN10 program. Otsuka will acquire all assets r...
Merger And AcquisitionsRepare Therapeutics announced it out-licensed its discovery platforms, including the SNIPRx platform and related intellectual property, to DCx Biother...
Mergers and acquisitionsMelinta Therapeutics, a commercial-stage biopharmaceutical company focused on acute and life-threatening illnesses, has been acquired by CorMedix Inc....
Mergers and acquisitionsGate Bioscience, a biotechnology company focused on molecular gate technology, announced a collaboration and license agreement with Eli Lilly and Comp...
Mergers and acquisitionsInnovent Biologics and Takeda have entered into a global strategic partnership to co-develop and commercialize Innovent's next-generation immuno-oncol...
Mergers and acquisitionsAleraCare, a provider of infusion and specialty pharmacy services, and PURE Healthcare, a medical group specializing in treating chronic conditions, a...
Mergers and acquisitionsMaxCyte and Moonlight Bio have entered into a Strategic Platform License agreement. Moonlight Bio will utilize MaxCyte’s Flow Electroporation® technol...
Mergers and acquisitionsChugai Pharmaceutical and Gero PTE. LTD. have entered a joint research and license agreement to develop novel antibody therapies for age-related disea...
Mergers and acquisitionsPolpharma Biologics and MS Pharma have signed licensing agreements for the commercialization of three biosimilar candidates: vedolizumab (PB016), ocre...
Mergers and acquisitionsNovartis announced its acquisition of Tourmaline Bio, a clinical-stage biopharmaceutical company, for approximately $1.4 billion. The acquisition cen...
Mergers and acquisitionsEnChannel Medical announced the acquisition of Acutus Medical's AcQMap™ High Resolution Imaging and Mapping platform assets. This acquisition strength...
Mergers and acquisitionsRoche has entered into a definitive merger agreement to acquire 89bio, Inc., a clinical-stage biopharmaceutical company, for up to $3.5 billion. The a...
Mergers and acquisitionsBoehringer Ingelheim and AimedBio have entered into a global collaboration and licensing agreement to develop a novel antibody-drug conjugate (ADC) th...
Mergers and acquisitionsSanofi announced its acquisition of Vigil Neuroscience, a clinical-stage biotechnology company focused on neurodegenerative diseases. This acquisitio...
Mergers and acquisitionsCRISPR Therapeutics and Sirius Therapeutics announced a multi-target collaboration to co-develop and co-commercialize SRSD107, a long-acting siRNA the...
Mergers and acquisitionsLakeShore Biopharma Co., Ltd. announced the receipt of a revised preliminary non-binding proposal from a consortium (Oceanpine Capital and Crystal Pea...
Mergers and acquisitionsAbbVie has completed its acquisition of Capstan Therapeutics, gaining access to CPTX2309, a first-in-class in vivo targeted lipid nanoparticle (tLNP) ...
Mergers and acquisitionsMallinckrodt plc and Endo, Inc. have completed their merger, forming a global leader in diversified therapeutics. The combined company boasts a broad ...
Merger and Acquisitionsbluebird bio, Inc. announced that it has received all necessary regulatory approvals for its acquisition by Carlyle and SK Capital. The merger is exp...
Mergers and acquisitionsMedtronic plc announced that its planned new diabetes company, resulting from an intended separation, will be named MiniMed. This name honors the com...
Mergers and acquisitionsBioNTech, a global immunotherapy company, announced its intent to acquire CureVac, a clinical-stage biotech company focused on mRNA-based therapies, i...
Mergers and acquisitionsMerck has agreed to acquire Verona Pharma for approximately $10 billion. This acquisition brings Ohtuvayre (ensifentrine), a first-in-class COPD main...
Mergers and acquisitionsCorMedix Inc. announced a definitive agreement to acquire Melinta Therapeutics LLC for $300 million. This acquisition significantly expands CorMedix's...
Mergers and acquisitionsPierre Fabre Laboratories announced the acquisition of worldwide rights for PFL-721 and PFL-241, mutant-specific EGFR inhibitors, from Antares Therape...
Mergers and acquisitionsNovartis AG will acquire Avidity Biosciences for USD 72.00 per share in cash, valuing the company at approximately USD 12.0 billion. Avidity will sepa...
Mergers and acquisitionsElutia Inc. has finalized the sale of its BioEnvelope business, including EluPro™ and CanGaroo® bioenvelopes, to Boston Scientific Corporation for $88...
Mergers and acquisitionsQuell Therapeutics announced that AstraZeneca has exercised its option to license a lead Treg cell therapy candidate from their joint Inflammatory Bow...
Mergers and acquisitionsBiofrontera Inc. announced the acquisition of all US assets related to Ameluz® and RhodoLED®, including the NDA and associated patents, from Biofronte...
Mergers and acquisitionsRepare Therapeutics has entered into an exclusive worldwide licensing agreement with Debiopharm for lunresertib, a first-in-class PKMYT1 inhibitor. D...
Mergers and acquisitionsFujirebio Diagnostics, a subsidiary of Fujirebio Holdings, Inc., has acquired Plasma Services Group, Inc., a provider of high-quality biological mater...
Mergers and acquisitionsRyboDyn, a biotechnology company developing first-in-class immunotherapies targeting the 'dark proteome' (previously uncharacterized proteins), has be...
Mergers and acquisitionsAdaptimmune Therapeutics plc announced the sale of its TECELRA, lete-cel, afami-cel, and uza-cel cell therapies to US WorldMeds for $55 million in cas...
Mergers and acquisitionsHengrui Pharma and GSK have entered into agreements to co-develop up to 12 innovative medicines across respiratory, immunology & inflammation, and onc...
Mergers and acquisitions23andMe, a genetics-led consumer healthcare company, has received court approval for the sale of substantially all of its assets to TTAM Research Inst...
Mergers and acquisitionsAbbVie announced the acquisition of Gilgamesh Pharmaceuticals' bretisilocin, a novel Phase 2 psychedelic compound for treating moderate-to-severe majo...
Mergers and acquisitionsBiocon Biologics and Civica expand their partnership to include Insulin Glargine, aiming to increase the availability of affordable insulin for the 38...
Mergers and acquisitionsDemetra, a medical company specializing in bone cements and biomaterials, announced the acquisition of OrthoFundamentals, a provider of single-use sol...
Mergers and acquisitionsAkero Therapeutics, a clinical-stage company focused on metabolic diseases, has entered into a definitive agreement to be acquired by Novo Nordisk for...
Private by design. Speaks your language. Proven at scale
